Volume | 7 |
|
|||||
News | (1) | ||||||
Day High | Low High |
||||||
Day Low |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Royal Phillips NV (PK) | RYLPF | OTCMarkets | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
26.242 | 26.242 |
Trades | Shares Traded | Average Volume | 52 Week Range |
---|---|---|---|
2 | 7 | - | 17.78 - 28.98 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
14:44:06 | 2 | US$ 26.94 | USD |
Royal Phillips NV (PK) Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
23.17B | 909.65M | - | 18.17B | -466M | -0.51 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Royal Phillips NV (PK) News
Date | Time | Source | News Article |
---|---|---|---|
5/16/2024 | 16:52 | Edgar (US Regulatory) | Form SC 13D/A - General statement of acquisition of.. |
5/14/2024 | 10:06 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in.. |
5/08/2024 | 08:09 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
2/20/2024 | 08:03 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
2/20/2024 | 07:22 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
2/20/2024 | 05:58 | Edgar (US Regulatory) | Form 20-F - Annual and transition report of foreign private.. |
2/06/2024 | 08:36 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
12/20/2023 | 06:16 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
10/23/2023 | 07:38 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
8/23/2023 | 11:44 | Edgar (US Regulatory) | Form SC 13D - General statement of acquisition of beneficial.. |
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical RYLPF Price Data
Period †| Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
1 Month | 20.17 | 28.98 | 20.17 | 23.70 | 29,317 | 6.07 | 30.10% |
3 Months | 20.17 | 28.98 | 19.80 | 23.07 | 10,664 | 6.07 | 30.10% |
6 Months | 20.83 | 28.98 | 19.544 | 22.20 | 9,401 | 5.41 | 25.98% |
1 Year | 20.661 | 28.98 | 17.78 | 21.46 | 8,415 | 5.58 | 27.01% |
3 Years | 56.448 | 58.48 | 11.956 | 22.70 | 48,726 | -30.21 | -53.51% |
5 Years | 40.43 | 61.06 | 11.956 | 28.00 | 36,743 | -14.19 | -35.09% |
Royal Phillips NV (PK) Description
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips' health technology portfolio generated 2017 sales of EUR 17.8 billion and employs approximately 74,000 employees with sales and services in more than 100 countries. |